These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 8095062

  • 21. Acute myeloid leukemia M4 with inv(16) (p13q22) exhibits a specific immunophenotype with CD2 expression.
    Paietta E, Wiernik PH, Andersen J, Bennett J, Yunis J.
    Blood; 1993 Oct 15; 82(8):2595. PubMed ID: 8104541
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Activated lymphocytes during acute Epstein-Barr virus infection.
    Tomkinson BE, Wagner DK, Nelson DL, Sullivan JL.
    J Immunol; 1987 Dec 01; 139(11):3802-7. PubMed ID: 3119718
    [Abstract] [Full Text] [Related]

  • 26. A novel subset of CD2-, CD3/T cell receptor alpha/beta+ human peripheral blood T cells. Phenotypic and functional characterization of interleukin 2-dependent CD2-CD3+ T cell clones.
    Kabelitz D, Conradt P, Schondelmaier S, Wagner H, Haars R.
    J Exp Med; 1989 Aug 01; 170(2):559-69. PubMed ID: 2569027
    [Abstract] [Full Text] [Related]

  • 27. Serum soluble E-selectin levels in Kawasaki disease.
    Kim DS, Lee KY.
    Scand J Rheumatol; 1994 Aug 01; 23(5):283-6. PubMed ID: 7526448
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Kawasaki disease.
    Samuel J, O'Sullivan J.
    Br J Hosp Med; 1994 Aug 01; 55(1-2):9-14. PubMed ID: 8646401
    [Abstract] [Full Text] [Related]

  • 31. Serum soluble CD8 antigen level is not elevated in mucocutaneous lymph node syndrome (Kawasaki disease) in spite of an increase in serum soluble interleukin 2 receptors.
    Furumoto H, Sakano T, Tanabe A, Hara M, Ida N.
    Eur J Pediatr; 1990 Mar 01; 149(6):448-9. PubMed ID: 2332021
    [No Abstract] [Full Text] [Related]

  • 32. Serum soluble CD4 and CD8 levels in Kawasaki disease.
    Furukawa S, Matsubara T, Tsuji K, Motohashi T, Okumura K, Yabuta K.
    Clin Exp Immunol; 1991 Oct 01; 86(1):134-9. PubMed ID: 1914226
    [Abstract] [Full Text] [Related]

  • 33. [Changes in CD69, CD25 and HLA-DR expressions in peripheral blood T cells in Kawasaki disease].
    Zhang YY, Huang XM, Kang ML, Gong FQ, Qian BQ.
    Zhonghua Er Ke Za Zhi; 2006 May 01; 44(5):329-32. PubMed ID: 16780706
    [Abstract] [Full Text] [Related]

  • 34. Immunologic abnormalities in Kawasaki syndrome.
    Leung DY.
    Prog Clin Biol Res; 1987 May 01; 250():159-65. PubMed ID: 3501125
    [No Abstract] [Full Text] [Related]

  • 35. [Serum soluble CD4 and CD8 levels in Kawasaki disease].
    Motohashi T.
    Arerugi; 1992 Feb 01; 41(2 Pt 1):140-7. PubMed ID: 1567283
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Mononuclear cell subsets and coronary artery lesions in Kawasaki disease.
    Furukawa S, Matsubara T, Yabuta K.
    Arch Dis Child; 1992 Jun 01; 67(6):706-8. PubMed ID: 1378258
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Histiocytic haemophagocytosis in a patient with Kawasaki disease: changes in the hypercytokinaemic state.
    Ohga S, Ooshima A, Fukushige J, Ueda K.
    Eur J Pediatr; 1995 Jul 01; 154(7):539-41. PubMed ID: 7556319
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.